Thyroid guide · Hashimoto's and menopause

Hashimoto's in menopause: when two hormonal shifts meet

Tired, sleepless, a few extra kilos, thinner hair: is it menopause or your thyroid? Sometimes it's both. Here you'll learn how the two shifts interact and which values can bring clarity.

SJ
Shukri Jarmoukli · Physician, Integrative Medicine · ViveCura Berlin
26 verified sourcesKPNI perspectiveReading time approx. 16 minutesUpdated: November 2026
Why I'm writing this

Many women around 50 hear two sentences. The first: That's menopause. The second: Your thyroid is well adjusted. Both can be true. But sometimes only one of them is, and that is exactly where precious time in your life gets lost.

I bet you know this feeling.

It's three in the morning, and you're wide awake. First you're too warm, then you shiver. In the morning, more hair stays in the brush than it used to. Your head feels full of cotton wool, and halfway through a sentence a word escapes you. And at some point you stand in front of the mirror and quietly ask yourself: Is this still me?

Your friend says: menopause. The scale shows two extra kilos, even though you're not doing anything differently. Maybe she's right about menopause. But maybe it's only half the story.

Because it's exactly at this stage of life that the thyroid also speaks up in many women. Two hormonal systems are changing at the same time. And they speak a surprisingly similar language.

I know this pattern very well. A woman around 50 sits across from me, very busy at work. She is convinced she is in the middle of menopause. Her cycle has become irregular, and she sleeps badly.

Her words: “I don't recognize myself anymore. I'm tired, I'm gaining weight even though I'm not doing anything differently, and my hair is falling out. It's just hormones, right?”

We didn't just look at her TSH, but also at the free thyroid hormones, the antibodies and the ultrasound image. The finding was clear: behind part of her symptoms was a thyroid that had slipped out of balance, against the background of Hashimoto's thyroiditis.

The turning point was a simple insight: two things were happening at the same time here. Her thyroid was adjusted step by step under medical care, with check-ups at set intervals. Menopause continued in parallel, and we took it just as seriously.

Over the following months, she reported that her energy and clarity slowly came back and her weight became more stable. Some hot flashes remained, because they belonged to menopause. I cannot claim causality, but I document the temporal connection.

The lesson: two things can be true at the same time. If you only look for one, you often only find one.

These two languages are exactly what this article is about. I'll show you where they overlap and which values can tell them apart. And what you can pay attention to if you take levothyroxine and are thinking about hormone therapy.

What to expect here

  • Why both often coincide
  • Hormones and the immune system in conversation
  • When symptoms wear a disguise
  • Estrogen and your levothyroxine needs
  • Which lab values can bring clarity
  • Bones, heart and weight
  • Selenium and vitamin D, honestly assessed
  • Three levers for the coming weeks

So you can always see how solid a statement is, I mark the evidence like this:

Clinical randomized trials and meta-analyses Human observational studies in people Mechanism reviews of mechanisms Practice my observation, not a study

Two shifts, one stage of life

Imagine two weather fronts. One is slowly moving in. The other may have been there for a long time, just quietly. And right around 50, they collide. No wonder you can no longer tell which way the wind is blowing.

The first front is Hashimoto's thyroiditis. Here the immune system turns against your own thyroid tissue. It is considered one of the most common autoimmune diseases of all (Ralli 2020). Over the years, it can gradually throttle the thyroid's hormone production.

Clinical · Meta-analysisThe study: Hashimoto's worldwide

A research team led by Hu from Shanghai analyzed 48 studies on how common Hashimoto's is among adults worldwide. On average, 7.5 percent were affected, women about four times as often as men.

What this means for you: Hashimoto's is not a rare exception, and as a woman you belong to the group with a much higher risk.

Hu X, Chen Y, Shen Y et al. Front Public Health. 2022;10:1020709. PMID 36311599 · DOI: 10.3389/fpubh.2022.1020709 [Meta-analysis, k=48]
Human · Population studyThe study: NHANES III

Hollowell and team measured thyroid values and antibodies in more than 17,000 people in the US population study NHANES III. Around 11 percent of people without known thyroid disease had TPO antibodies, women more often than men, with the share rising with age.

What this means for you: As the years go by, the likelihood rises that your thyroid, too, ends up in the immune system's sights.

Hollowell JG, Staehling NW, Flanders WD et al. J Clin Endocrinol Metab. 2002;87(2):489-99. PMID 11836274 · DOI: 10.1210/jcem.87.2.8182 [Real-world, cross-sectional, n=17,353]

The second front is menopause. Years before your last period, perimenopause begins, a phase in which estrogen and progesterone become restless. How early this can start, I explain in Perimenopause: symptoms and when it starts.

How often do the two fronts meet? The American SWAN study examined more than 3,200 women aged 42 to 52. In 9.6 percent, TSH was outside the range of 0.5 to 5.0 (Sowers 2003). So almost one in ten women in midlife had abnormal thyroid values.

7.5%of adults worldwide have Hashimoto's, averaged across 48 studies
4×as many women as men are affected by Hashimoto's
11.3%of people without known thyroid disease had TPO antibodies in NHANES III
9.6%of women aged 42 to 52 had a TSH outside 0.5 to 5.0
The reframe

From everything we know today, menopause does not directly cause Hashimoto's. It is more the moment when two curves cross: the risk of thyroid autoimmunity, which rises with age, and the hormonal remodeling.

So the question is rarely either/or. The question is: which part, and how much?

What you can take away from this: If you're around 50 and no longer recognize yourself, your thyroid belongs on the list too. Not instead of menopause, but in addition to it.

And now you know why the question of menopause or thyroid is so often framed too narrowly: it may well be that both apply at the same time.

Hormones and the immune system: an orchestra in transition

Maybe you've already had the feeling that your body no longer listens to you. That everything is tipping at once: sleep, mood, energy, skin. This feeling is not imagined. It has a biology.

In KPNI, clinical psychoneuroimmunology, I never look at one organ alone. The nervous system, immune system, metabolism and hormones are connected like the instruments of an orchestra. When one section changes the tempo, all the others have to follow.

Hormones: a roller coaster, not a staircase

In perimenopause, the orchestra grows restless. Estrogen and progesterone don't decline gently, like going down a staircase. They swing more like a roller coaster, sometimes high, sometimes low, often different from one cycle to the next.

The immune system: hormones have a say

Estrogen is far more than a reproductive hormone. Immune cells also carry docking sites for it, the estrogen receptors. So sex hormones have a say in the immune system. This is considered one reason why autoimmune diseases affect women much more often.

In Hashimoto's, the immune system targets, among other things, TPO, thyroid peroxidase. The thyroid uses this enzyme to build its hormones. So antibodies against TPO show: the immune system has the hormone workshop in its sights.

Mechanism · ReviewThe review: hormonal transitions

Desai and Brinton brought together how the risk of autoimmune disease in women changes across the hormonal transitions of life. Puberty, pregnancy and menopause appear in it as phases in which sex hormones and the immune system reorganize together.

What this means for you: It is plausible that your immune system also finds a new balance during menopause, but the details are still open.

Desai MK, Brinton RD. Front Endocrinol (Lausanne). 2019;10:265. PMID 31110493 · DOI: 10.3389/fendo.2019.00265 [Mechanism review]

And the thyroid itself? Thyroid diseases are more common in women, especially between puberty and menopause. Thyroid cells also carry estrogen receptors, alpha and beta. One review describes how estrogen can directly influence the growth and function of these cells (Santin 2011). Mechanistically plausible, but the details in humans are still thinly supported.

According to current understanding, Hashimoto's itself arises from an interplay of genes, environment and epigenetic influences (Ralli 2020). Hormones are one thread in this web, not the only one. You'll find more on this in Hashimoto's thyroiditis: causes and the immune system. What role environmental factors such as heavy metals might play, you can read in Heavy metals and Hashimoto's.

Nerves and sleep: the quiet chain

Practice Clinically, I observe that many women first notice the decline in progesterone in their sleep. Falling asleep becomes harder, and nights become shallower. This is an observation from my practice, not a finding from a study.

Poor sleep puts strain on the stress axis. A stress axis that stays tense for a long time can in turn keep the immune system restless. Mechanistically plausible, but human studies on this exact chain are thin. How stress, cortisol and exhaustion are connected, you can read in Cortisol, the stress axis and burnout.

Metabolism: two hands on one dial

Thyroid hormones are something like the gas pedal of every cell. They help determine how much energy the mitochondria provide. If estrogen drops at the same time, fat distribution and muscle mass change. So two systems are turning the same dial. How closely the thyroid and female hormones are linked throughout life, you can read in Thyroid and female hormones.

Staying honest

It has not been shown that menopause itself triggers Hashimoto's. In the SWAN study, TSH was not related to the stage of menopause (Sowers 2003).

A review in the journal Climacteric considers it unclear whether menopause affects the thyroid independently of aging. It does, however, describe that menopause can change how an autoimmune thyroid condition presents (del Ghianda 2014).

The reframe

Positive TPO antibodies are like a smoke detector, not the fire itself. They show that the immune system has its eye on the thyroid. Whether and when this turns into hypothyroidism is a different question.

A beeping smoke detector is no reason to panic. But it is a good reason to check in regularly.

What you can do: Pay attention to patterns rather than single symptoms. If your sleep, mood and energy change at the same time, it's worth looking at several systems instead of just one.

And now you know why so much shifts at once during menopause: hormones, the immune system, nerves and metabolism all play in the same orchestra.

Same symptoms, two possible sources

You're sitting in the doctor's office, listing: tired, irritable, sleeping badly, gaining weight. And you notice yourself how vague that sounds. That is exactly the difficulty. These symptoms fit menopause. But they fit just as well with a thyroid that no longer delivers enough.

Your thyroid and menopause can disguise themselves like two guests in the same costume. From the outside, you only see the costume. Only when you look more closely can you tell who is inside.

SymptomMay come from the thyroidMay come from menopauseTip for evaluation
Fatigue, exhaustionHypothyroidism slows energy metabolismHot flashes at night rob you of sleepLook at TSH, fT4, fT3 and ferritin together
Weight gainA higher TSH goes along with slightly more weight (Fox 2008)Fat gain speeds up during the transition (Greendale 2019)Trend and waist circumference rather than a single weigh-in
Mood, anxietyAutoimmune thyroiditis is linked to depression and anxiety (Siegmann 2018)Hormone fluctuations can change moodTake mental health symptoms seriously and check both levels
Sleep problemsA hyperthyroid phase or too much levothyroxine can make you restlessHot flashes and falling progesteroneNote exactly when your sleep tips over
Hair loss, dry skinHypothyroidism can change skin and hairFalling estrogen changes skin and hairInclude ferritin
Cycle changesAn abnormal TSH goes along with shorter or longer periods (Sowers 2003)Irregular cycles are part of perimenopauseKeep a cycle diary
Palpitations, feeling hotHashimoto's can also show up with hyperthyroidism at first (Caturegli 2014)Hot flashes, palpitations at nightCheck TSH and fT4, especially during treatment
Concentration, finding wordsHypothyroidism can slow thinkingMany women describe brain fogDocument the course over several weeks

This table does not replace a diagnosis. Iron deficiency, sleep apnea, depression and other causes can produce the same symptoms too.

Human · Population studyThe study: SWAN

Sowers and team examined more than 3,200 women aged 42 to 52 in the SWAN study and compared TSH with menopause symptoms. Of more than 15 symptoms, only anxiety was related to an abnormal TSH, along with shorter or longer menstrual bleeding.

What this means for you: Symptoms alone can hardly tell you whether it's your thyroid or menopause speaking.

Sowers M, Luborsky J, Perdue C et al. Clin Endocrinol (Oxf). 2003;58(3):340-7. PMID 12608940 · DOI: 10.1046/j.1365-2265.2003.01718.x [Real-world, cross-sectional, n=3,242]
Human · Comparative studyThe study: symptoms and lab values

Canaris and team checked in 223 people how well classic symptoms of hypothyroidism match the lab values. Newly changed symptoms revealed more than long-standing ones, and with seven or more such changes, hypothyroidism was considerably more likely.

What this means for you: It's not the single symptom that counts, but the pattern and the change over time.

Canaris GJ, Steiner JF, Ridgway EC. J Gen Intern Med. 1997;12(9):544-50. PMID 9294788 · DOI: 10.1046/j.1525-1497.1997.07109.x [Real-world, cross-sectional, n=223]
Clinical · Meta-analysisThe study: thyroid and mental health

A team led by Siegmann in Erlangen combined 19 studies with more than 36,000 participants on autoimmune thyroiditis and mental health. The odds of depression were about 3.6-fold higher, and those of anxiety disorders about 2.3-fold higher, with individual studies varying widely.

What this means for you: Low moods during menopause deserve a look at the thyroid too, instead of being blamed on hormones alone.

Siegmann EM, Müller HHO, Luecke C et al. JAMA Psychiatry. 2018;75(6):577-584. PMID 29800939 · DOI: 10.1001/jamapsychiatry.2018.0190 [Systematic review and meta-analysis, k=19]

Another analysis from SWAN, with almost 3,300 women and 58 recorded symptoms, shows the tangle even more clearly. Hot flashes often occurred together with sleep problems and fatigue. And around a quarter of the women were already moderately to severely burdened before menopause (Harlow 2017). The title of the paper sums it up: it is not just menopause.

Conversely, the thyroid does not seem to have much influence on typical menopause symptoms such as hot flashes (del Ghianda 2014). This explains why some symptoms can remain even with a well-adjusted thyroid. They then belong to menopause.

The reframe

Your symptoms aren't vague because you're exaggerating. They're vague because two systems speak the same language.

The art is not in finding the one right symptom. It's in checking both sources.

What you can do: For four weeks, write down what you feel and when. Include your cycle day, sleep and mood. This diary is worth its weight in gold for the conversation with your doctor, because it makes patterns visible.

And now you know why your symptoms alone rarely reveal where they come from: your thyroid and menopause can leave the same traces.

Estrogen and levothyroxine: the taxi principle

Imagine your thyroid has been well adjusted for years. Then you start hormone therapy for your hot flashes. A few weeks later, you're tired again, you feel cold, your head feels heavy. And you ask yourself: Is this my fault now?

Not necessarily. It could be down to a transport protein in your blood: TBG, thyroxine-binding globulin.

More taxis, fewer free passengers

Imagine TBG as a taxi in your blood. Most thyroid hormones ride in these taxis. Only the passengers standing free on the sidewalk can walk into the cells and do their work there. These are the free hormones, fT4 and fT3.

Estrogen taken as a pill passes through the liver first. There, it orders more taxis, so to speak: the liver produces more TBG. More taxis mean more bound hormone and fewer free passengers (Mazer 2004).

A healthy thyroid notices this and simply sends out more hormone. With Hashimoto's and levothyroxine, that often no longer works. The amount comes from the pill, and your own gland can barely add more.

Human · Prospective studyThe study: New England Journal of Medicine

Arafah followed 36 postmenopausal women for 48 weeks from the start of estrogen therapy, 25 of them with treated hypothyroidism. In those with hypothyroidism, free T4 fell, and in 7 of 18 women on replacement therapy, TSH rose above 7 mU/L.

What this means for you: When hormone therapy starts, your thyroid should be checked by a doctor in the following weeks.

Arafah BM. N Engl J Med. 2001;344(23):1743-9. PMID 11396440 · DOI: 10.1056/NEJM200106073442302 [Real-world, prospective study, n=36]

The comparison is fascinating: in the women with a healthy thyroid, TBG also rose markedly, but free T4 and TSH stayed stable. Their feedback loop balanced out the extra demand on its own. This is exactly the balance that is missing when Hashimoto's has used up the thyroid's reserves.

Pill or skin: the route makes a difference

Clinical · Randomized trialThe study: pill or skin

Shifren and team gave 25 postmenopausal women estrogen as a pill and through the skin, one after the other, in random order. On the pill, TBG rose by 38 percent, while through the skin it did not change substantially.

What this means for you: The route by which estrogen enters your body can make a difference to your thyroid values.

Shifren JL, Rifai N, Desindes S et al. J Clin Endocrinol Metab. 2008;93(5):1702-10. PMID 18303079 · DOI: 10.1210/jc.2007-2193 [RCT, crossover, n=25]

One small caveat: in this study, not only the routes differed, but also the types of estrogen. The pill contained conjugated estrogens, the skin route estradiol.

A review by Mazer estimates that about five percent of all postmenopausal women take estrogen and thyroid hormone at the same time. It considers the route through the skin a possible alternative, because it does not raise TBG (Mazer 2004). For transparency: the author worked for a pharmaceutical company at the time and is a co-author of the Shifren study.

The American Thyroid Association guideline on treating hypothyroidism also describes estrogen as a factor that can change how much levothyroxine you need (Jonklaas 2014). And a review on the thyroid and menopause emphasizes: the decision for or against hormone therapy remains individual, regardless of a thyroid condition (Uygur 2018).

Supported by studies in humans: Estrogen taken as a pill raises TBG, and in treated hypothyroidism this can make TSH rise. Mechanistically plausible, human studies thin: that estrogen through the skin also keeps levothyroxine needs stable over the long term. Clinically, I observe: Many women first notice such a shift as returning fatigue.

Important before you change anything

Never change your levothyroxine dose or your hormone therapy on your own. Every adjustment belongs in medical hands and is checked with a new measurement.

When hormone therapy starts, switches or ends, bring up a check of your thyroid values. In the Arafah study, the rise in TBG was clearly measurable after twelve weeks. Your doctor will decide the exact timing of the check.

Mechanistically, the reverse also applies: if estrogen taken as a pill is stopped, TBG falls again. The same amount of levothyroxine can then become too much over time. In that case, too, a check is worthwhile.

The reframe

If you become tired again on a new hormone therapy, you haven't done anything wrong. It could simply be the taxi principle: more taxis, fewer free passengers.

This is not a personal failure, but a measurable shift. And measurable shifts are something your doctor can fine-tune in a targeted way.

What you can do: With every change to your hormone therapy, actively ask about your thyroid. And mention the form, pill or through the skin. If you still have symptoms despite treatment, feel free to read Levothyroxine, and the symptoms remain.

And now you know why hormone therapy can shift your thyroid values: estrogen taken as a pill orders more taxis, and with Hashimoto's your thyroid often cannot send enough extra passengers.

Which lab values can bring clarity

Maybe you know this sentence: Your thyroid is fine. And yet you went home thinking: But I'm not.

Often a single value is behind this sentence, usually TSH. As a screening test, that makes sense. For Hashimoto's in menopause, it is often not enough. A single value is like a photo. What you need is more like a short film: several values and how they change over time.

The full picture

  • TSH: the call from headquarters. The pituitary gland reports how much thyroid hormone it would like. A rising TSH means: too little is arriving.
  • fT4 instead of total T4: Because estrogen changes the number of taxis, total T4 reveals little. Free T4 shows the passengers who actually arrive.
  • fT3: the active hormone. How well T4 is converted into T3, I explain in T4 to T3: understanding conversion and in Understanding reverse T3.
  • TPO antibodies: the smoke detector. They show whether the immune system has the thyroid in its sights.
  • Tg antibodies: an addition. In NHANES III, they were not linked to a functional disorder on their own (Hollowell 2002). As an addition to TPO antibodies, they can still round out the picture.
  • Ultrasound: A hypoechoic pattern, together with the antibodies, can support the diagnosis of Hashimoto's (Caturegli 2014).
  • Ferritin and blood lipids: Ferritin shows your iron stores, important for the thyroid and hair. Blood lipids can rise when the thyroid slows down (Canaris 2000).
Human · Long-term studyThe study: Whickham, 20 years

Vanderpump and team followed almost 2,800 adults from Whickham in England for twenty years. Women with elevated TSH and antibodies had 38-fold higher odds of later hypothyroidism, and with only one of the two findings, 8-fold higher odds.

What this means for you: Positive antibodies are not a verdict, but they are a good reason for regular check-ups.

Vanderpump MP, Tunbridge WM, French JM et al. Clin Endocrinol (Oxf). 1995;43(1):55-68. PMID 7641412 · DOI: 10.1111/j.1365-2265.1995.tb01894.x [Real-world, cohort, n=2,779]
Human · Population studyThe study: TSH and age

Surks and Hollowell broke down the TSH values of the US population without known thyroid disease by age group. A TSH above 2.5 was found in 10.6 percent of people aged 20 to 29, but in 40 percent of those over 80.

What this means for you: A TSH value always needs to be read in context, with age, antibodies and symptoms.

Surks MI, Hollowell JG. J Clin Endocrinol Metab. 2007;92(12):4575-82. PMID 17911171 · DOI: 10.1210/jc.2007-1499 [Real-world, cross-sectional]

Especially interesting for your age group: among people aged 40 to 49 with a TSH above 4.5, two thirds had thyroid antibodies (Surks 2007). So an elevated TSH in midlife is often a sign of autoimmunity.

And adjusted once does not mean adjusted forever. In the Colorado study of almost 26,000 people, 40 percent of those taking thyroid medication had a TSH outside the reference range (Canaris 2000). Especially when hormones are shifting, regular checks are worthwhile.

And the sex hormones? FSH and estradiol fluctuate strongly in perimenopause. A single value therefore often says little about where you currently stand. How you can put menopause as a whole into context, you can read in Menopause: symptoms and what may help.

Practice Clinically, I use ferritin values above 100 as my guide. This is my orientation from practice, not an official laboratory standard. Why iron, the thyroid and sleep are connected, I explain in Iron deficiency, thyroid and sleep.

Why ferritin can be misleading when there is inflammation, you can read in Iron, inflammation and hepcidin. And why iron sometimes gets stuck as early as the stomach, I explain in Low stomach acid as an overlooked cause.

One more practical point: Ask in advance whether you should take your levothyroxine only after the blood draw on the morning of the test. This can make the values easier to compare.

If your values are within the reference range and you still don't feel well, you'll find more in Normal thyroid values and still symptoms and in Functional hypothyroidism. Which values count in detail, I explain in Thyroid blood tests: which ones matter.

The reframe

An unremarkable TSH is good news, but it is not the whole picture. Clarity only emerges when TSH, free hormones, antibodies and the course over time are read together.

You are not asking too much when you ask for the whole picture. You are asking for what can make sense in your stage of life.

What I would take away from this section

A value is a photo. Several values over time are a film. For Hashimoto's in menopause, you need the film.

And now you know why a single TSH value is rarely enough during menopause: only several values over time show how your thyroid is doing.

Bones, heart, weight: why the right adjustment matters

Maybe you're thinking: The main thing is that I feel fit again. A little more levothyroxine, and the fatigue is gone. That wish is so understandable. But especially after menopause, the thyroid has a long reach: all the way into your bones and into your heart.

As estrogen declines, your bones lose an important protection. At the same time, the risk for your heart and blood vessels changes. It is exactly in this phase that the question of how your thyroid is adjusted comes up.

Reviews describe that atherosclerosis and osteoporosis can worsen when the thyroid is not properly adjusted (del Ghianda 2014). High doses of levothyroxine can strain the heart and increase bone turnover (Uygur 2018).

Clinical · Meta-analysisThe study: thyroid and fractures

Blum and team jointly analyzed data from more than 70,000 people from 13 cohorts on thyroid values and fractures. Mild hyperthyroidism was associated with a 36 percent higher risk of hip fractures, whereas mild hypothyroidism was not.

What this means for you: A TSH that stays too low is not harmless for your bones, especially after menopause.

Blum MR, Bauer DC, Collet TH et al. JAMA. 2015;313(20):2055-65. PMID 26010634 · DOI: 10.1001/jama.2015.5161 [Meta-analysis, 13 cohorts, n=70,298]
Human · Long-term studyThe study: TSH on levothyroxine

Flynn and team followed almost 17,700 people on long-term levothyroxine therapy over several years. TSH values that were too high or strongly suppressed went along with more cardiovascular disease and fractures, while slightly low values did not.

What this means for you: On levothyroxine, the goal is not the lowest TSH, but the right one.

Flynn RW, Bonellie SR, Jung RT et al. J Clin Endocrinol Metab. 2010;95(1):186-93. PMID 19906785 · DOI: 10.1210/jc.2009-1625 [Real-world, cohort, n=17,684]

And the heart? A pooled analysis of 11 cohorts with more than 55,000 people looked at exactly this. With a TSH between 10 and 19.9, the risk of heart events was almost doubled, with a hazard ratio of 1.89. With a TSH between 4.5 and 6.9, however, there was no increased risk, and overall mortality was not increased (Rodondi 2010).

1.36hazard ratio for hip fractures with mild hyperthyroidism
2.02hazard ratio for fractures with strongly suppressed TSH on levothyroxine
1.89hazard ratio for heart events with TSH 10 to 19.9
2×faster fat gain during the menopause transition

And your weight?

This is where both come together. In a large population study from the US, women in the highest TSH quarter weighed 70.2 kilos on average, and those in the lowest 64.5. And all of this within the reference range (Fox 2008). Over three and a half years, a rising TSH went along with 0.5 to 2.3 extra kilos.

At the same time, the body remodels itself during the transition. In the SWAN study, the rate at which fat increased doubled at the start of the transition, while lean mass declined. This continued until about two years after the last period (Greendale 2019).

The two can add up. The thyroid is one factor, rarely the only one. Which cofactors your energy metabolism needs, you can read in Micronutrients for energy and metabolism.

The reframe

The goal is not the lowest TSH, but the right one. More hormone does not automatically mean more energy.

Sometimes the best adjustment is the one you barely notice, and that can still take strain off your bones and your heart.

What you can do: Don't just ask whether your values are within the range. Also ask where exactly within the range, and whether that suits your age, your bones and your heart.

And now you know why adjusting the thyroid after menopause takes so much finesse: too little and too much can both come at a price.

Selenium and vitamin D: what the studies show

Maybe you've read in a forum that selenium lowers antibodies. Or that vitamin D changes everything with Hashimoto's. The hope behind this is understandable. You want to be able to do something. So let's take an honest look together.

Selenium is a trace element that the thyroid needs for its enzymes. It is part of the deiodinases, which convert T4 into active T3, and of protective enzymes against oxidative stress. Mechanistically, it makes sense to think of selenium in Hashimoto's.

Clinical · Meta-analysisThe study: selenium in Hashimoto's

Huwiler and team in Bern combined 35 randomized trials on selenium in Hashimoto's. Selenium lowered TPO antibodies and, in people without hormone replacement, slightly lowered TSH, while fT4, fT3 and thyroid volume remained unchanged.

What this means for you: Selenium can lower antibodies, the evidence is considered moderate, and whether this changes the long-term course is still open.

Huwiler VV, Maissen-Abgottspon S, Stanga Z et al. Thyroid. 2024;34(3):295-313. PMID 38243784 · DOI: 10.1089/thy.2023.0556 [Meta-analysis, k=35]

Side effects occurred about as often in these trials as in the control groups. The results on antibodies, however, varied widely between the individual studies.

Clinical · Meta-analysisThe study: vitamin D in autoimmune thyroiditis

Wang and team analyzed six randomized trials with 344 people on vitamin D in autoimmune thyroiditis. After about six months, TPO antibodies fell, but not yet after three months or less, and no serious side effects were reported.

What this means for you: Vitamin D might influence the antibodies, but the data are small and short-term.

Wang S, Wu Y, Zuo Z, Zhao Y, Wang K. Endocrine. 2018;59(3):499-505. PMID 29388046 · DOI: 10.1007/s12020-018-1532-5 [Meta-analysis, k=6, n=344]

Supported by meta-analyses of randomized trials: Selenium can lower TPO antibodies, and for vitamin D there are first, smaller signals in the same direction. Still open: whether this changes symptoms or the long-term course.

Staying honest

Antibodies are a surrogate marker. Falling antibodies do not automatically mean that you feel better or that your thyroid holds out longer. That has not been shown so far.

Selenium has a narrow window: too little is unfavorable, too much can cause harm. Taking it therefore belongs under medical supervision, ideally after a measurement. The same applies to vitamin D: measure first, then decide together.

I am deliberately not giving specific doses here. They depend on your values, your diet and your overall situation.

You'll find more on the thyroid's micronutrients in Selenium, zinc, iron: micronutrients for the thyroid. What else might lower the antibodies, I have gathered in Hashimoto's antibodies: what might lower them. And why iodine calls for a delicate touch in Hashimoto's, I explain in Putting iodine and the thyroid in context.

How nutrition can influence the immune system in Hashimoto's, you can read in Nutrition for Hashimoto's: what may help.

The reframe

Selenium and vitamin D are building blocks, not a foundation. The foundation remains a properly adjusted thyroid, good sleep and a daily life that doesn't keep your immune system under constant strain.

On this foundation, building blocks can make sense. Without a foundation, they carry little weight.

What you can do: Have your vitamin D and, if needed, selenium measured before you take anything. And discuss the results with your doctor.

And now you know why selenium and vitamin D may give you hope, but don't promise miracles: the studies show effects on antibodies, not on everything you feel.

Three levers for the coming weeks

Maybe you feel a little overwhelmed after all these numbers. That's okay. You don't have to understand everything at once. You only need one next step.

It's not about a lab value. It's about waking up in the morning and recognizing yourself again. Clarity is freedom.

When you know which part of your symptoms comes from your thyroid and which from menopause, you can address both in a targeted way. Without this clarity, you're turning dials in the dark.

Your three levers

  • Lever 1, a four-week diary: Every evening, note your energy, sleep, mood, hot flashes and cycle day. Three minutes are enough. This makes patterns visible that would otherwise get lost in the conversation.
  • Lever 2, the full picture: Ask for TSH, fT4, fT3, TPO and Tg antibodies, and if needed an ultrasound and ferritin. Ask in advance whether you should take your levothyroxine only after the blood draw on the day of the test.
  • Lever 3, a check with every hormone change: If hormone therapy starts, switches or ends, plan a check of your thyroid values. Also talk about the form, pill or through the skin. Don't change anything on your own.
The reframe

You're not being difficult when you ask questions. You're taking responsibility for your health.

A well-prepared woman in the consulting room is a gain for every good doctor.

What I would take away from this article

The best question is not either/or, but which part, and how much. Menopause and Hashimoto's can be present at the same time. If you see both, you can address both in a targeted way.

And now you know why three clear steps can often achieve more than any single measure: they create clarity, and freedom begins with clarity.

Frequently asked questions about Hashimoto's in menopause

Does menopause cause Hashimoto's?

Based on current knowledge, not directly. Hashimoto's arises from an interplay of genes, environment and the immune system. The risk rises with age, and women are affected much more often. That is why Hashimoto's and menopause often coincide. Menopause can, however, change how an autoimmune thyroid condition shows up.

How do I tell menopause symptoms apart from an underactive thyroid?

Often barely at all from symptoms alone, because fatigue, weight gain, low moods and sleep problems fit both. Lab values can bring clarity: TSH, free T4 and T3, and the thyroid antibodies. A four-week symptom and cycle diary can also make the conversation with your doctor easier.

Does hormone therapy change how much levothyroxine I need?

That is possible. Estrogen taken as a pill raises the transport protein TBG via the liver, so less free thyroid hormone is available. In one study, TSH rose as a result in women with treated hypothyroidism. That is why your thyroid values should be checked by a doctor after starting, switching or stopping hormone therapy. Never change your dose on your own.

Is estrogen through the skin better if you have Hashimoto's?

In a randomized trial, estrogen as a pill raised TBG by 38 percent, while estrogen through the skin did not change it substantially. For your thyroid values, the route through the skin can therefore be more stable. Which form suits you, however, depends on many factors and is a shared decision with your doctor.

Which blood tests should I have done?

For a full picture, TSH, free T4, free T3, TPO antibodies and Tg antibodies are useful. A thyroid ultrasound, ferritin and blood lipids can be sensible additions. What matters is the trend over time, not a single value.

What do elevated TPO antibodies mean when TSH is normal?

They show that your immune system has the thyroid in its sights, like a smoke detector going off. This does not have to turn into hypothyroidism. In the Whickham study, however, women with antibodies had a higher risk of developing hypothyroidism later. Regular check-ups are therefore sensible.

Can selenium help with Hashimoto's in menopause?

A meta-analysis of 35 randomized trials shows that selenium can lower TPO antibodies, with moderate certainty of evidence. Whether this changes the long-term course is still open. Selenium has a narrow safety window, so taking it belongs under medical supervision, ideally after a measurement.

Does vitamin D play a role?

Possibly. A meta-analysis of six small trials found lower TPO antibodies with vitamin D after about six months. The data, however, are small and short-term. It makes sense to measure your vitamin D level first and then decide together.

Can a poorly adjusted thyroid harm your bones?

That is possible, especially with overtreatment. In a large analysis, mild hyperthyroidism was associated with a higher risk of hip fractures. On levothyroxine, a strongly suppressed TSH was linked to more fractures. That is why, especially after menopause, what counts is an adjustment that fits, not a maximal one.

Why am I gaining weight even though my thyroid is well adjusted?

During the menopause transition, the rate at which fat accumulates doubles on average, while lean mass declines. This happens even with a well-adjusted thyroid. In addition, a TSH in the upper reference range can be associated with slightly more weight. Usually several factors come together.

Does Hashimoto's rule out hormone therapy?

Not in principle. Reviews emphasize that the decision for or against hormone therapy is made individually, regardless of a thyroid condition. What matters is keeping an eye on your thyroid values when therapy starts and whenever it changes.

How the topics connect

Hashimoto's in menopause touches on several guides. Here you'll find the closest connections.

SJ

Shukri Jarmoukli

Physician, Integrative Medicine · ViveCura Berlin

In my practice, I combine conventional medicine with clinical psychoneuroimmunology (KPNI), functional medicine and anthroposophy. I'm interested in how the nervous system, immune system, metabolism and hormones work together, especially in phases of life when a lot changes at once.

This article does not replace medical advice and is not a guide to changing any medication. Please never adjust levothyroxine or hormone therapy without medical supervision.

ViveCura, private practice of Shukri Jarmoukli, Skalitzer Straße 137, 10999 Berlin

Scientific sources

  1. Ralli M, Angeletti D, Fiore M et al. Hashimoto's thyroiditis: An update on pathogenic mechanisms, diagnostic protocols, therapeutic strategies, and potential malignant transformation. Autoimmun Rev. 2020;19(10):102649. PMID: 32805423 · DOI: 10.1016/j.autrev.2020.102649 [Review]
  2. Hu X, Chen Y, Shen Y et al. Global prevalence and epidemiological trends of Hashimoto's thyroiditis in adults: A systematic review and meta-analysis. Front Public Health. 2022;10:1020709. PMID: 36311599 · DOI: 10.3389/fpubh.2022.1020709 [Meta-analysis, k=48]
  3. Hollowell JG, Staehling NW, Flanders WD et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87(2):489-99. PMID: 11836274 · DOI: 10.1210/jcem.87.2.8182 [Real-world, cross-sectional, n=17,353]
  4. Sowers M, Luborsky J, Perdue C et al. Thyroid stimulating hormone (TSH) concentrations and menopausal status in women at the mid-life: SWAN. Clin Endocrinol (Oxf). 2003;58(3):340-7. PMID: 12608940 · DOI: 10.1046/j.1365-2265.2003.01718.x [Real-world, cross-sectional, n=3,242]
  5. Desai MK, Brinton RD. Autoimmune Disease in Women: Endocrine Transition and Risk Across the Lifespan. Front Endocrinol (Lausanne). 2019;10:265. PMID: 31110493 · DOI: 10.3389/fendo.2019.00265 [Mechanism review]
  6. Santin AP, Furlanetto TW. Role of estrogen in thyroid function and growth regulation. J Thyroid Res. 2011;2011:875125. PMID: 21687614 · DOI: 10.4061/2011/875125 [Mechanism review]
  7. del Ghianda S, Tonacchera M, Vitti P. Thyroid and menopause. Climacteric. 2014;17(3):225-34. PMID: 23998691 · DOI: 10.3109/13697137.2013.838554 [Review]
  8. Fox CS, Pencina MJ, D'Agostino RB et al. Relations of thyroid function to body weight: cross-sectional and longitudinal observations in a community-based sample. Arch Intern Med. 2008;168(6):587-92. PMID: 18362250 · DOI: 10.1001/archinte.168.6.587 [Real-world, cohort, n=2,407]
  9. Greendale GA, Sternfeld B, Huang M et al. Changes in body composition and weight during the menopause transition. JCI Insight. 2019;4(5):e124865. PMID: 30843880 · DOI: 10.1172/jci.insight.124865 [Real-world, cohort, SWAN]
  10. Siegmann EM, Müller HHO, Luecke C et al. Association of Depression and Anxiety Disorders With Autoimmune Thyroiditis: A Systematic Review and Meta-analysis. JAMA Psychiatry. 2018;75(6):577-584. PMID: 29800939 · DOI: 10.1001/jamapsychiatry.2018.0190 [Systematic review and meta-analysis, k=19]
  11. Caturegli P, De Remigis A, Rose NR. Hashimoto thyroiditis: clinical and diagnostic criteria. Autoimmun Rev. 2014;13(4-5):391-7. PMID: 24434360 · DOI: 10.1016/j.autrev.2014.01.007 [Review]
  12. Canaris GJ, Steiner JF, Ridgway EC. Do traditional symptoms of hypothyroidism correlate with biochemical disease? J Gen Intern Med. 1997;12(9):544-50. PMID: 9294788 · DOI: 10.1046/j.1525-1497.1997.07109.x [Real-world, cross-sectional, n=223]
  13. Harlow SD, Karvonen-Gutierrez C, Elliott MR et al. It is not just menopause: symptom clustering in the Study of Women's Health Across the Nation. Womens Midlife Health. 2017;3:2. PMID: 29326841 · DOI: 10.1186/s40695-017-0021-y [Real-world, cohort, n=3,289]
  14. Arafah BM. Increased need for thyroxine in women with hypothyroidism during estrogen therapy. N Engl J Med. 2001;344(23):1743-9. PMID: 11396440 · DOI: 10.1056/NEJM200106073442302 [Real-world, prospective study, n=36]
  15. Shifren JL, Rifai N, Desindes S et al. A comparison of the short-term effects of oral conjugated equine estrogens versus transdermal estradiol on C-reactive protein, other serum markers of inflammation, and other hepatic proteins in naturally menopausal women. J Clin Endocrinol Metab. 2008;93(5):1702-10. PMID: 18303079 · DOI: 10.1210/jc.2007-2193 [RCT, crossover, n=25]
  16. Mazer NA. Interaction of estrogen therapy and thyroid hormone replacement in postmenopausal women. Thyroid. 2004;14 Suppl 1:S27-34. PMID: 15142374 · DOI: 10.1089/105072504323024561 [Review]
  17. Jonklaas J, Bianco AC, Bauer AJ et al. Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement. Thyroid. 2014;24(12):1670-751. PMID: 25266247 · DOI: 10.1089/thy.2014.0028 [Review, guideline]
  18. Uygur MM, Yoldemir T, Yavuz DG. Thyroid disease in the perimenopause and postmenopause period. Climacteric. 2018;21(6):542-548. PMID: 30296186 · DOI: 10.1080/13697137.2018.1514004 [Review]
  19. Vanderpump MP, Tunbridge WM, French JM et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf). 1995;43(1):55-68. PMID: 7641412 · DOI: 10.1111/j.1365-2265.1995.tb01894.x [Real-world, cohort, n=2,779]
  20. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160(4):526-34. PMID: 10695693 · DOI: 10.1001/archinte.160.4.526 [Real-world, cross-sectional, n=25,862]
  21. Surks MI, Hollowell JG. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab. 2007;92(12):4575-82. PMID: 17911171 · DOI: 10.1210/jc.2007-1499 [Real-world, cross-sectional]
  22. Blum MR, Bauer DC, Collet TH et al. Subclinical thyroid dysfunction and fracture risk: a meta-analysis. JAMA. 2015;313(20):2055-65. PMID: 26010634 · DOI: 10.1001/jama.2015.5161 [Meta-analysis, 13 cohorts, n=70,298]
  23. Flynn RW, Bonellie SR, Jung RT et al. Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy. J Clin Endocrinol Metab. 2010;95(1):186-93. PMID: 19906785 · DOI: 10.1210/jc.2009-1625 [Real-world, cohort, n=17,684]
  24. Rodondi N, den Elzen WPJ, Bauer DC et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 2010;304(12):1365-74. PMID: 20858880 · DOI: 10.1001/jama.2010.1361 [Meta-analysis, 11 cohorts, n=55,287]
  25. Huwiler VV, Maissen-Abgottspon S, Stanga Z et al. Selenium Supplementation in Patients with Hashimoto Thyroiditis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Thyroid. 2024;34(3):295-313. PMID: 38243784 · DOI: 10.1089/thy.2023.0556 [Meta-analysis, k=35]
  26. Wang S, Wu Y, Zuo Z, Zhao Y, Wang K. The effect of vitamin D supplementation on thyroid autoantibody levels in the treatment of autoimmune thyroiditis: a systematic review and a meta-analysis. Endocrine. 2018;59(3):499-505. PMID: 29388046 · DOI: 10.1007/s12020-018-1532-5 [Meta-analysis, k=6, n=344]
Transparency about the evidenceMost of the studies cited here are observational studies. They show associations, not causes. Antibodies are surrogate markers and do not automatically say anything about how you feel. The review by Mazer comes from an author who worked for a pharmaceutical company at the time and is a co-author of the Shifren study. Observations from my practice are marked as such and do not replace a study. All sources were checked in PubMed, as of November 2026.

Have questions or want to book an appointment?

We'd be happy to advise you personally at our practice.

Book appointment